|
1.
|
HB El-SeragHepatocellular carcinomaN Engl
J Med36511181127201110.1056/NEJMra100168321992124
|
|
2.
|
I IkaiM KudoS AriiReport of the 18th
follow-up survey of primary liver cancer in JapanHepatol
Res4010431059201010.1111/j.1872-034X.2010.00731.x
|
|
3.
|
R LencioniLoco-regional treatment of
hepatocellular
carcinomaHepatology52762773201010.1002/hep.2372520564355
|
|
4.
|
Y OkuwakiT NakazawaA ShibuyaIntrahepatic
distant recurrence after radiofrequency ablation for a single small
hepatocellular carcinoma: risk factors and patternsJ
Gastroenterol437178200810.1007/s00535-007-2123-z
|
|
5.
|
N IzumiPrediction and prevention of
intrahepatic recurrence of hepatocellular carcinomaHepatol
Res42226232201210.1111/j.1872-034X.2011.00922.x22181559
|
|
6.
|
F KorangyB HöchstMP MannsTF GretenImmune
responses in hepatocellular carcinomaDig
Dis28150154201010.1159/00028207920460904
|
|
7.
|
J BanchereauRM SteinmanDendritic cells and
the control of immunityNature392245252199810.1038/32588
|
|
8.
|
M OnjiSM AkbarDendritic Cells in
Clinics2nd editionSpringerTokyo2008
|
|
9.
|
J BanchereauAK PaluckaDendritic cells as
therapeutic vaccines against cancerNat Rev
Immunol5296306200510.1038/nri159215803149
|
|
10.
|
FO NestleA FarkasC
ConradDendritic-cell-based therapeutic vaccination against
cancerCurr Opin
Immunol17163169200510.1016/j.coi.2005.02.00315766676
|
|
11.
|
A LadhamsC SchmidtG SingTreatment of
nonresectable hepatocellular carcinoma with autologous tumor-pulsed
dendritic cellsJ Gastroenterol
Hepatol17889896200210.1046/j.1440-1746.2002.02817.x12164965
|
|
12.
|
Y IwashitaK TaharaS GotoA phase I study of
autologous dendritic cell-based immunotherapy for patients with
unresectable primary liver cancerCancer Immunol
Immunother52155161200312649744
|
|
13.
|
A StiftJ FriedlP DubskyDendritic
cell-based vaccination in solid cancerJ Clin
Oncol21135142200310.1200/JCO.2003.02.13512506182
|
|
14.
|
T KumagiSM AkbarN HoriikeAdministration of
dendritic cells in cancer nodules in hepatocellular carcinomaOncol
Rep14969973200516142359
|
|
15.
|
KH ChiSJ LiuCP LiCombination of conformal
radiotherapy and intratumoral injection of adoptive dendritic cell
immunotherapy in refractory hepatomaJ
Immunother28129135200510.1097/01.cji.0000154248.74383.5e15725956
|
|
16.
|
WC LeeHC WangCF HungPF HuangCR LiaMF
ChenVaccination of advanced hepatocellular carcinoma patients with
tumor lysate-pulsed dendritic cells: a clinical trialJ
Immunother28496504200510.1097/01.cji.0000171291.72039.e216113606
|
|
17.
|
LH ButterfieldA RibasVB DissetteA phase
I/II trial testing immunization of hepatocellular carcinoma
patients with dendritic cells pulsed with four alpha-fetoprotein
peptidesClin Cancer
Res1228172825200610.1158/1078-0432.CCR-05-2856
|
|
18.
|
Y NakamotoE MizukoshiH TsujiCombined
therapy of transcatheter hepatic arterial embolization with
intratumoral dendritic cell infusion for hepatocellular carcinoma:
clinical safetyClin Exp
Immunol147296305200710.1111/j.1365-2249.2006.03290.x
|
|
19.
|
DH PalmerRS MidgleyN MirzaA phase II study
of adoptive immunotherapy using dendritic cells pulsed with tumor
lysate in patients with hepatocellular
carcinomaHepatology49124132200910.1002/hep.2262618980227
|
|
20.
|
Y NakamotoE MizukoshiM KitaharaProlonged
recurrence-free survival following OK432-stimulated dendritic cell
transfer into hepatocellular carcinoma during transarterial
embolizationClin Exp
Immunol163165177201110.1111/j.1365-2249.2010.04246.x
|
|
21.
|
D KimC JeonJH KimCytoplasmic transduction
peptide (CTP): new approach for the delivery of biomolecules into
cytoplasm in vitro and in vivoExp Cell
Res31212771288200610.1016/j.yexcr.2005.12.02916466653
|
|
22.
|
JH KimY LeeYS BaePhase I/II study of
immunotherapy using autologous tumor lysate-pulsed dendritic cells
in patients with metastatic renal cell carcinomaClin
Immunol125257267200710.1016/j.clim.2007.07.01417916447
|
|
23.
|
P TherasseSG ArbuckEA EisenhauerNew
guidelines to evaluate the response to treatment in solid tumors
European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of CanadaJ Natl Cancer
Inst92205216200010.1093/jnci/92.3.205
|
|
24.
|
LH ButterfieldImmunotherapeutic strategies
for hepatocellular carcinomaGastroenterology127Suppl
1S232S241200410.1053/j.gastro.2004.09.03815508089
|
|
25.
|
TF GretenMP MannsF KorangyImmunotherapy of
HCCRev Recent Clin Trials33139200810.2174/157488708783330549
|
|
26.
|
P MatarL AlanizV RozadosImmunotherapy for
liver tumors: present status and future prospectsJ Biomed
Sci1630200910.1186/1423-0127-16-3019272130
|
|
27.
|
LA OrmandyT HillemannH WedemeyerMP MannsTF
GretenF KorangyIncreased populations of regulatory T cells in
peripheral blood of patients with hepatocellular carcinomaCancer
Res6524572464200510.1158/0008-5472.CAN-04-323215781662
|
|
28.
|
B HoechstLA OrmandyM BallmaierA new
population of myeloid-derived suppressor cells in hepatocellular
carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T
cellsGastroenterology135234243200818485901
|
|
29.
|
T NinomiyaSM AkbarT MasumotoN HoriikeM
OnjiDendritic cells with immature phenotype and defective function
in the peripheral blood from patients with hepatocellular
carcinomaJ
Hepatol31323331199910.1016/S0168-8278(99)80231-110453947
|
|
30.
|
S KakumuS ItoT IshikawaDecreased function
of peripheral blood dendritic cells in patients with hepatocellular
carcinoma with hepatitis B and C virus infectionJ Gastroenterol
Hepatol15431436200010.1046/j.1440-1746.2000.02161.x10824889
|
|
31.
|
D McIlroyM GregoireOptimizing dendritic
cell-based anticancer immunotherapy: maturation state does have
clinical impactCancer Immunol
Immunother52583591200310.1007/s00262-003-0414-712827310
|
|
32.
|
RM PrinsN CraftKW BruhnThe TLR-7 agonist,
imiquimod, enhances dendritic cell survival and promotes tumor
antigen-specific T cell priming: relation to central nervous system
antitumor immunityJ
Immunol176157164200610.4049/jimmunol.176.1.157
|
|
33.
|
LH ButterfieldA RibasWS MengT-cell
responses to HLA-A*0201 immunodominant peptides derived from
alpha-fetoprotein in patients with hepatocellular cancerClin Cancer
Res9590259082003
|
|
34.
|
E MizukoshiY NakamotoK AraiComparative
analysis of various tumor-associated antigen-specific T-cell
responses in patients with hepatocellular
carcinomaHepatology5312061216201110.1002/hep.2414921480325
|
|
35.
|
T NakatsuraY YoshitakeS SenjuGlypican-3,
over-expressed specifically in human hepatocellular carcinoma, is a
novel tumor markerBiochem Biophys Res
Commun3061625200310.1016/S0006-291X(03)00908-212788060
|
|
36.
|
Y MotomuraS SenjuT NakatsuraEmbryonic stem
cell-derived dendritic cells expressing glypican-3, a recently
identified oncofetal antigen, induce protective immunity against
highly metastatic mouse melanoma, B16-F10Cancer
Res6624142422200610.1158/0008-5472.CAN-05-2090
|
|
37.
|
K SuzukiS TsujitaniI KonishiY YamaguchiY
HirookaN KaibaraExpression of MAGE genes and survival in patients
with hepatocellular carcinomaInt J Oncol1512271232199910568832
|
|
38.
|
K KariyamaT HigashiY KobayashiExpression
of MAGE-1 and -3 genes and gene products in human hepatocellular
carcinomaBr J
Cancer8110801087199910.1038/sj.bjc.669081010576668
|
|
39.
|
J O’BeirneF FarzanehPM HarrisonGeneration
of functional CD8+ T cells by human dendritic cells
expressing glypican-3 epitopesJ Exp Clin Cancer Res29482010
|
|
40.
|
JS LeeSS ThorgeirssonGenome-scale
profiling of gene expression in hepatocellular carcinoma:
classification, survival prediction, and identification of
therapeutic targetsGastroenterology127Suppl
1S51S55200410.1053/j.gastro.2004.09.01515508103
|
